TRL Total Renal Care Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TRL Total Renal Care

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wmj who wrote ()	3/9/1999 3:45:00 PM
From: wmj	of 36

TOTAL RENAL CARE HOLDINGS (TRL) 03/05/99 Stock Under Pressure; Recommend Purchse Rating: BUY Change: None 12-Mo. Target: $$low 20's Total Renal Care shares came under heavy selling pressure yesterday. We met with the CEO and the CFO of the company last evening. Despite controversy from several issues surrounding the fundamentals of the company, we believe the stock is extremely attractive at current levels and we reiterate our purchase recommendation for investors willing to take some risk for the potential of appreciation. For the record, we are lowering our EPS estimate for 1999 from a range of $1.50-1.65 to a range of $1.40-1.50. We believe TRL will achieve the high end of that range, but we are allowing for the possibility that the SEC might require a change in amortization policy that might reduce EPS by about $0.05 annually. Essentially, we assume TRL is capable of, and will adopt a goal of, 20% or better EPS growth from the $1.22 reported last year. (8:30 AM EST)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next